BindingDB logo
myBDB logout

BDBM203350 US9539260, B14::US9763952, Example B14

SMILES: COc1ncc(cc1C(F)(F)F)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12

InChI Key: InChIKey=FIKICNBUTIASAB-IBGZPJMESA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 203350   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform


(Homo sapiens (Human))
BDBM203350
PNG
(US9539260, B14 | US9763952, Example B14)
Show SMILES COc1ncc(cc1C(F)(F)F)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r|
Show InChI InChI=1S/C25H28F3N3O6S/c1-35-23-20(25(26,27)28)12-17(14-29-23)31-8-9-36-22-3-2-18(13-21(22)31)37-19-4-7-30(15-19)24(32)16-5-10-38(33,34)11-6-16/h2-3,12-14,16,19H,4-11,15H2,1H3/t19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 244n/an/an/an/an/a25



NOVARTIS AG

US Patent


Assay Description
Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1...


US Patent US9539260 (2017)


BindingDB Entry DOI: 10.7270/Q2W37TH1
More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203350
PNG
(US9539260, B14 | US9763952, Example B14)
Show SMILES COc1ncc(cc1C(F)(F)F)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r|
Show InChI InChI=1S/C25H28F3N3O6S/c1-35-23-20(25(26,27)28)12-17(14-29-23)31-8-9-36-22-3-2-18(13-21(22)31)37-19-4-7-30(15-19)24(32)16-5-10-38(33,34)11-6-16/h2-3,12-14,16,19H,4-11,15H2,1H3/t19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/an/an/a



NOVARTIS AG

US Patent




US Patent US9763952 (2017)


BindingDB Entry DOI: 10.7270/Q2V40X9Z
More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform


(Homo sapiens (Human))
BDBM203350
PNG
(US9539260, B14 | US9763952, Example B14)
Show SMILES COc1ncc(cc1C(F)(F)F)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r|
Show InChI InChI=1S/C25H28F3N3O6S/c1-35-23-20(25(26,27)28)12-17(14-29-23)31-8-9-36-22-3-2-18(13-21(22)31)37-19-4-7-30(15-19)24(32)16-5-10-38(33,34)11-6-16/h2-3,12-14,16,19H,4-11,15H2,1H3/t19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 244n/an/an/an/an/an/a



NOVARTIS AG

US Patent


Assay Description
The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p...


US Patent US9763952 (2017)


BindingDB Entry DOI: 10.7270/Q2V40X9Z
More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203350
PNG
(US9539260, B14 | US9763952, Example B14)
Show SMILES COc1ncc(cc1C(F)(F)F)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r|
Show InChI InChI=1S/C25H28F3N3O6S/c1-35-23-20(25(26,27)28)12-17(14-29-23)31-8-9-36-22-3-2-18(13-21(22)31)37-19-4-7-30(15-19)24(32)16-5-10-38(33,34)11-6-16/h2-3,12-14,16,19H,4-11,15H2,1H3/t19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/an/a25



NOVARTIS AG

US Patent


Assay Description
Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1...


US Patent US9539260 (2017)


BindingDB Entry DOI: 10.7270/Q2W37TH1
More data for this
Ligand-Target Pair